Viewing Study NCT00486356

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:14 PM
Ignite Modification Date: 2026-02-28 @ 5:31 AM
Study NCT ID: NCT00486356
Status: COMPLETED
Last Update Posted: 2024-01-03
First Post: 2007-06-13
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer
Sponsor: University of Nebraska
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Extrahepatic Bile Duct Cancer View
None Gallbladder Cancer View
None Gastric Cancer View
None Liver Cancer View
None Unspecified Adult Solid Tumor, Protocol Specific View
Keywords:

Keywords

Keyword Brief Keyword Text View
None unspecified adult solid tumor, protocol specific View
None recurrent gastric cancer View
None stage IV gastric cancer View
None advanced adult primary liver cancer View
None localized unresectable adult primary liver cancer View
None recurrent adult primary liver cancer View
None recurrent extrahepatic bile duct cancer View
None unresectable extrahepatic bile duct cancer View
None recurrent gallbladder cancer View
None unresectable gallbladder cancer View